Unlike the non-TNBC type of breast cancers, TNBC tumors belong to the biologically aggressive type of breast cancer and cannot be managed with targeted, endocrine, or HER2/neu-directed therapies [4–6]. This evidence concerns the gene ERBB2 and breast cancer.